Jamie Hartmann-Boyce

My research mainly consists of applied evidence synthesis for health policy, including in the areas of tobacco control, electronic cigarettes, diet, physical activity, and management of long-term conditions. I have a particular interest in diabetes, having lived with type 1 diabetes since childhood. I work closely with Cochrane and lead a number of research programs focusing on smoking cessation and electronic cigarettes. I am also involved in developing methods for evidence synthesis and primary research, including quantitative and qualitative synthesis and work on incorporating equity considerations into systematic reviews. I am passionate about communicating complex information and data to inform policy and public action. I work hard to engage the public in my research and have been involved in podcasts, blogging, tv and radio interviews, and songwriting to communicate research results outside of academia.

Conflict of Interest Disclosure:

I have many international collaborations. I work closely with colleagues at the University of Oxford, England (where I was based for many years), and PI two Cancer Research UK funded grants (I do not receive funding from these grants). I also write a regular summary of e-cigarette literature for Cancer Research UK. I have given a talk and served on a scientific committee for the French National Cancer Institute (INCa). I sit on Health Canada’s Scientific Advisory Board for Vaping Products, and peer review grant proposals for the Canadian Institute of Health Research (CIHR). I have been contracted by the World Health Organization (WHO), Geneva, Switzerland, to conduct research relating to the COVID-19 pandemic. I am often interviewed by international media outlets. Other than the work for the WHO (which involved payments to my institution to cover the resources required), this international work is unpaid.